Company / Current Assets
SUTRO BIOPHARMA, INC. Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$150.9M
FY2025
5-year range
$150.9M / $421.5M
FY2021-FY2025
Trend
-56.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 8 years, ranging from $129M in FY2019 to $422M in FY2023.
Based on SEC 10-K filings.
$151M in FY2025 with a 5-year CAGR of -16.8%.
Declined from $422M to $151M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -24.7%
- 5-Year CAGR
- -16.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -16.8%, indicating a declining trend.
- In FY2025, current assets decreased 56.0% year-over-year.
- Peak current assets was recorded in FY2023.
- Lowest current assets in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -3.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $150.9M | -56.0% |
| FY2024 | $343.3M | -18.6% |
| FY2023 | $421.5M | +19.4% |
| FY2022 | $353.2M | +61.6% |
| FY2021 | $218.5M | -42.2% |
| FY2020 | $378.2M | +194.1% |
| FY2019 | $128.6M | -38.8% |
| FY2018 | $209.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026